[1] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022[J]. CA A Cancer J Clinicians, 2022, 72(1): 7-33. doi:  10.3322/caac.21708
[2] 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肿瘤学分会肺癌临床诊疗指南(2021版)[J]. 中华肿瘤杂志, 2021, 43(6): 591-621. doi:  10.3760/cma.j.cn112152-20210207-00118
[3] LU T, YANG X D, HUANG Y W, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades[J]. Cancer Manag Res, 2019, 11: 943-953. doi:  10.2147/CMAR.S187317
[4] 谢雅革, 沈克平, 卢艳琳. 中医药治疗非小细胞肺癌研究进展[J]. 中华中医药杂志, 2021, 36(5): 2846-2851.
[5] 狄冠麟, 朱振刚, 郑延龙. 中西医结合治疗中晚期非小细胞肺癌的临床研究进展[J]. 癌症进展, 2021, 19(12): 1202-1206.
[6] 贺天临, 谢国群, 陈洁, 等. 夏枯草消瘤合剂联合化疗治疗中晚期非小细胞肺癌30例[J]. 上海中医药大学学报, 2015, 29(5): 29-32.
[7] 戴媛媛. 夏枯草消瘤合剂体内药代动力学研究及其对非小细胞肺癌基因表达谱的影响[D]. 上海: 上海中医药大学, 2020.
[8] KANG D Y, SP N, LEE J M, et al. Antitumor effects of ursolic acid through mediating the inhibition of STAT3/PD-L1 signaling in non-small cell lung cancer cells[J]. Biomedicines, 2021, 9(3): 297. doi:  10.3390/biomedicines9030297
[9] XIANG M, JIANG H G, SHU Y, et al. Bisdemethoxycurcumin enhances the sensitivity of non-small cell lung cancer cells to icotinib via dual induction of autophagy and apoptosis[J]. Int J Biol Sci, 2020, 16(9): 1536-1550. doi:  10.7150/ijbs.40042
[10] ZHAO Z X, LIU B J, SUN J, et al. Scutellaria flavonoids effectively inhibit the malignant phenotypes of non-small cell lung cancer in an Id1-dependent manner[J]. Int J Biol Sci, 2019, 15(7): 1500-1513. doi:  10.7150/ijbs.33146
[11] MIN J, SHEN H, XI W, et al. Synergistic anticancer activity of combined use of caffeic acid with paclitaxel enhances apoptosis of non-small-cell lung cancer H1299 cells in vivo and in vitro[J]. Cell Physiol Biochem, 2018, 48(4): 1433-1442. doi:  10.1159/000492253
[12] ZENG J, HUANG T, XUE M, et al. Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review[J]. RSC Adv, 2018, 8(43): 24188-24202. doi:  10.1039/C8RA03666G
[13] RAJAVEL T, PRIYA G B, SURYANARAYANAN V, et al. Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism[J]. Eur J Pharmacol, 2019, 855: 112-123. doi:  10.1016/j.ejphar.2019.04.051
[14] RAJAVEL T, PACKIYARAJ P, SURYANARAYANAN V, et al. β-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation[J]. Sci Rep, 2018, 8(1): 2071. doi:  10.1038/s41598-018-20311-6
[15] 汪帅, 孙宇, 李春梅, 等. 豆甾醇的研究进展概述[J]. 中国药业, 2019, 28(23): 96-98. doi:  10.3969/j.issn.1006-4931.2019.23.031
[16] 信波, 庞海林, 申炜炜, 等. 雌二醇对非小细胞肺癌A549细胞迁移及侵袭能力的影响[J]. 山西医科大学学报, 2021, 52(8): 945-950.
[17] GAO X J, CAI Y, WANG Z, et al. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective[J]. J Transl Med, 2019, 17(1): 308. doi:  10.1186/s12967-019-2056-3
[18] 郑旭, 韩燕燕, 李翀. MAPK信号传导通路在非小细胞肺癌中的研究进展[J]. 江苏医药, 2020, 46(12): 1278-1281.
[19] CHEN N, FANG W F, LIN Z, et al. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma[J]. Cancer Immunol Immunother, 2017, 66(9): 1175-1187. doi:  10.1007/s00262-017-2005-z
[20] 张瑞新, 宁方玲. 肿瘤细胞衰老及相关治疗的研究进展[J]. 中国医药科学, 2022, 12(9): 62-65. doi:  10.3969/j.issn.2095-0616.2022.09.017
[21] HERRANZ N, GIL J. Mechanisms and functions of cellular senescence[J]. J Clin Invest, 2018, 128(4): 1238-1246. doi:  10.1172/JCI95148
[22] 费彦亢, 黄晨玮, 于兵. 细胞衰老在肿瘤治疗应用中的研究进展[J]. 医学研究生学报, 2022, 35(3): 312-317.
[23] CHOU J C, LIEU F K, HO D M, et al. Regulation of extracellular and intracellular prolactin on cell proliferation and survival rate through GHR/JAK2/STAT3 pathway in NSCLC[J]. Chemosphere, 2021, 264(Pt 1): 128604.
[24] FANG R, ZHU Y, KHADKA V S, et al. The evaluation of serum biomarkers for non-small cell lung cancer(NSCLC)diagnosis[J]. Front Physiol, 2018, 9: 1710. doi:  10.3389/fphys.2018.01710
[25] BOUILLY J, SONIGO C, AUFFRET J, et al. Prolactin signaling mechanisms in ovary[J]. Mol Cell Endocrinol, 2012, 356(1-2): 80-87. doi:  10.1016/j.mce.2011.05.004
[26] FAN L L, ZHANG B C, XU A X, et al. Carrier-free, pure nanodrug formed by the self-assembly of an anticancer drug for cancer immune therapy[J]. Mol Pharm, 2018, 15(6): 2466-2478. doi:  10.1021/acs.molpharmaceut.8b00444
[27] 廉政君, 常炜. 汉黄芩素调节JAK/STAT信号通路并诱导肺癌A549细胞凋亡及周期阻滞的作用及机制研究[J]. 临床肺科杂志, 2021, 26(2): 270-274,279. doi:  10.3969/j.issn.1009-6663.2021.02.023
[28] STAPELFELD C, DAMMANN C, MASER E. Sex-specificity in lung cancer risk[J]. Int J Cancer, 2020, 146(9): 2376-2382. doi:  10.1002/ijc.32716
[29] RODRIGUEZ-LARA V, HERNANDEZ-MARTINEZ J M, ARRIETA O. Influence of estrogen in non-small cell lung cancer and its clinical implications[J]. J Thorac Dis, 2018, 10(1): 482-497. doi:  10.21037/jtd.2017.12.61
[30] 戴媛媛, 马明华, 徐晓红, 等. LC-MS/MS法测定大鼠血浆中夏枯草消瘤合剂有效成分体内药动学研究[J]. 药学实践与服务, 2023, 41(06): 358-365.